Form 4: Herbalife Director Rodica Macadrai Awarded 11,879 RSUs

Herbalife Ltd. director Rodica Macadrai has been granted 11,879 restricted stock units as part of the company's 2023 Stock Incentive Plan.

Summary

• Rodica Macadrai, a Director at Herbalife Ltd., was granted 11,879 restricted stock units (RSUs) on May 8, 2026.
• The RSUs were issued at a price of $0.00 as part of the company's Amended and Restated 2023 Stock Incentive Plan.
• Following this transaction, Macadrai's total direct ownership in the company increased to 67,441 shares.
• The granted units are scheduled to vest 100% on April 15, 2027, contingent upon continued service on the Board of Directors.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive administrative event, showing continued insider alignment without significant market impact.

Positives

• Increased insider equity alignment with shareholder interests.
• Director's total beneficial ownership has grown to 67,441 shares.
• The vesting schedule encourages long-term commitment to the board through April 2027.

Negatives

• The grant represents a potential future dilution of existing shares, although the volume is relatively low compared to total shares outstanding.

Risks

• Vesting is subject to continued service; if the director leaves the board before April 15, 2027, the units may be forfeited.

Future Outlook

The grant indicates a continued strategy of using equity-based compensation to retain board members and align their interests with long-term corporate performance through 2027.

Industry Context

StockSavvy.ai notes that equity-based compensation for directors is a standard practice in the health and wellness industry to ensure governance is aligned with market performance and shareholder returns.

Comparison to Industry Standards

• The use of RSUs with a one-year cliff vesting period is consistent with S&P 500 board compensation trends.
• Herbalife's 2023 Stock Incentive Plan aligns with peer companies like Nu Skin Enterprises and USANA Health Sciences in terms of director equity structures.

Corporate Governance

Related Party Transactions

• The grant of equity to a director is a standard related party transaction disclosed under SEC rules.

Stakeholder Impact

• Shareholders may see minor dilution upon vesting, but benefit from director alignment with long-term company goals.

Next Steps

• Vesting of 11,879 RSUs on April 15, 2027.

Key Dates

Recommendation

This is a routine compensation event and does not signal a change in company fundamentals or strategic direction that would warrant a change in investment rating.

Keywords

Herbalife Ltd., HLF, Insider Trading, Form 4, Restricted Stock Units, Rodica Macadrai, Director Compensation, Equity Grant